Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Activin A is a dimeric protein belonging to the transforming growth factor-beta (TGF-β) superfamily. It is composed of two βA subunits and functions as a hormone, growth factor, and cytokine. Activin A regulates numerous physiological processes including cellular proliferation and differentiation, embryonic development, reproductive function (notably by enhancing follicle-stimulating hormone biosynthesis), wound healing, bone formation and regeneration, immune modulation, and neuronal survival. In cancer biology, activin A promotes tumor cell growth and migration, contributes to immune evasion and cachexia (muscle wasting), and is associated with poor prognosis in several cancers. Elevated levels are implicated in diseases such as colorectal cancer, breast cancer (especially postmenopausal women), rheumatoid arthritis (joint inflammation), fibrodysplasia ossificans progressiva (FOP; abnormal bone formation), metabolic disorders like atherosclerosis (where it can be protective when expressed in the liver), pulmonary arterial hypertension via its signaling pathway effects on vascular remodeling/inflammation, as well as roles in stem cell differentiation toward mesoendodermal lineages[1][3][5][6][8]. Activin A exerts its effects by binding to type II activin receptors which recruit type I receptors leading to SMAD2/3 phosphorylation—a canonical TGF-β signaling cascade[4][5]. Its biological activity can be neutralized by inhibins or follistatin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on activin a.